Teplizumab approval for type 1 diabetes in the USA. Issue 2 (February 2023)

Record Type:: Journal Article
Title:: Teplizumab approval for type 1 diabetes in the USA. Issue 2 (February 2023)
Main Title:: Teplizumab approval for type 1 diabetes in the USA
Authors:: Kordonouri, Olga
Reschke, Felix
Danne, Thomas
Abstract:
Is Part Of:: Lancet. Volume 11:Issue 2(2023)
Journal:: Lancet
Issue:: Volume 11:Issue 2(2023)
Issue Display:: Volume 11, Issue 2 (2023)
Year:: 2023
Volume:: 11
Issue:: 2
Issue Sort Value:: 2023-0011-0002-0000
Page Start:: 77
Page End:: 78
Publication Date:: 2023-02
Subjects:: Diabetes -- Periodicals
Endocrinology -- Periodicals
Endocrine glands -- Diseases -- Periodicals
616.4
Journal URLs:: http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2213-8587(22)00391-6 ↗
Languages:: English
ISSNs:: 2213-8587
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.080050
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 25538.xml